-
Something wrong with this record ?
Mean diameter of nucleolar bodies in cultured human leukemic myeloblasts is mainly related to the S and G2 phase of the cell cycle
K. Smetana, K. Kuzelova, M. Zapotocky, J. Starkova, Z. Hrkal, J. Trka
Language English Country Italy
NLK
Free Medical Journals
from 2000
ProQuest Central
from 2000-01-01 to 2020-06-30
Open Access Digital Library
from 2003-01-01
Health & Medicine (ProQuest)
from 2000-01-01 to 2020-06-30
ROAD: Directory of Open Access Scholarly Resources
from 2000
- MeSH
- Leukemia, Erythroblastic, Acute genetics pathology MeSH
- Antigens, Nuclear MeSH
- Cell Nucleolus genetics pathology MeSH
- K562 Cells MeSH
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics pathology MeSH
- Financing, Organized MeSH
- G2 Phase physiology MeSH
- Nuclear Proteins MeSH
- Humans MeSH
- Nucleolus Organizer Region pathology MeSH
- Cell Count MeSH
- Granulocyte Precursor Cells pathology MeSH
- Cell Proliferation MeSH
- RNA, Neoplasm analysis MeSH
- S Phase physiology MeSH
- Check Tag
- Humans MeSH
Mean diameter of nucleolar bodies (nucleoli without the perinucleolar chromatin) per cell was studied in human leukemic myeloblasts represented by K 562 and Kasumi 1 cell lines which originated from chronic and acute myeloid leukaemia. The measurement of mean diameter of nucleolar bodies in specimens stained for RNA was very simple. Such approach eliminated the variability of the perinucleolar chromatin discontinuous shell which might influence the measured nucleolar size as suggested by earlier studies. Ageing of K 562 myeloblasts produced a significant decrease of cells in S+G2 phase of the cell cycle accompanied by a significant reduction of mean diameter of nucleolar bodies (MDNoBs) per cell. In contrast, treatment of Kasumi 1 myeloblasts with histone deacetylase inhibitor - Trichostatin A - produced a large incidence of resistant cells in S+G2 phase which were characterised by a large increase of MDNoBs. Thus, MDNoBs in leukemic myeloblasts might be a helpful tool to estimate the incidence of cells in the S+G2 phase at the single cell level in smear preparations when the number of cells is very small.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10025576
- 003
- CZ-PrNML
- 005
- 20120910175159.0
- 008
- 101014s2007 it e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Smetana, Karel, $d 1930- $7 nlk19990073860
- 245 10
- $a Mean diameter of nucleolar bodies in cultured human leukemic myeloblasts is mainly related to the S and G2 phase of the cell cycle / $c K. Smetana, K. Kuzelova, M. Zapotocky, J. Starkova, Z. Hrkal, J. Trka
- 314 __
- $a Institute of Hematology and Blood Transfusion, U nemocnice 1, Prague 2, Czech Republic, 128 20 karel.smetana@uhkt.cz.
- 520 9_
- $a Mean diameter of nucleolar bodies (nucleoli without the perinucleolar chromatin) per cell was studied in human leukemic myeloblasts represented by K 562 and Kasumi 1 cell lines which originated from chronic and acute myeloid leukaemia. The measurement of mean diameter of nucleolar bodies in specimens stained for RNA was very simple. Such approach eliminated the variability of the perinucleolar chromatin discontinuous shell which might influence the measured nucleolar size as suggested by earlier studies. Ageing of K 562 myeloblasts produced a significant decrease of cells in S+G2 phase of the cell cycle accompanied by a significant reduction of mean diameter of nucleolar bodies (MDNoBs) per cell. In contrast, treatment of Kasumi 1 myeloblasts with histone deacetylase inhibitor - Trichostatin A - produced a large incidence of resistant cells in S+G2 phase which were characterised by a large increase of MDNoBs. Thus, MDNoBs in leukemic myeloblasts might be a helpful tool to estimate the incidence of cells in the S+G2 phase at the single cell level in smear preparations when the number of cells is very small.
- 650 _2
- $a antigeny jaderné $7 D034961
- 650 _2
- $a počet buněk $7 D002452
- 650 _2
- $a buněčné jadérko $x genetika $x patologie $7 D002466
- 650 _2
- $a proliferace buněk $7 D049109
- 650 _2
- $a G2 fáze $x fyziologie $7 D016195
- 650 _2
- $a prekurzorové buňky granulocytů $x patologie $7 D042381
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a buňky K562 $7 D020014
- 650 _2
- $a akutní erytroblastická leukemie $x genetika $x patologie $7 D004915
- 650 _2
- $a akutní erytroblastická leukemie $7 D004915
- 650 _2
- $a chronická myeloidní leukemie $x genetika $x patologie $7 D015464
- 650 _2
- $a jaderné proteiny $7 D009687
- 650 _2
- $a organizátor jadérka $x patologie $7 D009697
- 650 _2
- $a RNA nádorová $x analýza $7 D012334
- 650 _2
- $a S fáze $x fyziologie $7 D016196
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Kuželová, Kateřina $7 xx0115456
- 700 1_
- $a Zápotocký, Michal $7 xx0099530
- 700 1_
- $a Starková, Júlia, $d 1977- $7 xx0106984
- 700 1_
- $a Hrkal, Zbyněk, $d 1934- $7 xx0059987
- 700 1_
- $a Trka, Jan, $d 1966- $7 xx0036261
- 773 0_
- $w MED00001622 $t European journal of histochemistry $g Roč. 51, č. 4 (2007), s. 269-274 $x 1121-760X
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20101020113629 $b ABA008
- 991 __
- $a 20120910175352 $b ABA008
- 999 __
- $a ok $b bmc $g 800544 $s 665413
- BAS __
- $a 3
- BMC __
- $a 2007 $b 51 $c 4 $d 269-274 $i 1121-760X $m European journal of histochemistry $n Eur J Histochem $x MED00001622
- LZP __
- $a 2010-B/jtme